Johnson & Johnson Price to Free Cash Flow Ratio 2006-2019 | JNJ

Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006.
Johnson & Johnson Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-08-16 131.36 7.09
2019-06-30 139.28 $18.54 7.51
2019-03-31 139.79 $17.76 7.87
2018-12-31 128.20 $17.68 7.25
2018-09-30 136.39 $16.86 8.09
2018-06-30 118.99 $16.53 7.20
2018-03-31 124.74 $15.97 7.81
2017-12-31 135.14 $15.75 8.58
2017-09-30 124.99 $14.63 8.54
2017-06-30 126.38 $13.55 9.33
2017-03-31 118.20 $12.95 9.13
2016-12-31 108.63 $12.65 8.59
2016-09-30 110.62 $13.58 8.15
2016-06-30 112.83 $14.67 7.69
2016-03-31 99.94 $15.44 6.47
2015-12-31 94.20 $15.74 5.99
2015-09-30 84.98 $15.63 5.44
2015-06-30 88.03 $16.36 5.38
2015-03-31 90.21 $16.41 5.50
2014-12-31 93.12 $16.70 5.58
2014-09-30 94.31 $14.81 6.37
2014-06-30 91.94 $13.02 7.06
2014-03-31 85.73 $12.16 7.05
2013-12-31 79.36 $11.63 6.83
2013-09-30 74.60 $11.63 6.41
2013-06-30 73.34 $11.66 6.29
2013-03-31 69.12 $11.92 5.80
2012-12-31 58.96 $12.25 4.81
2012-09-30 57.45 $11.87 4.84
2012-06-30 55.82 $11.45 4.88
2012-03-31 53.98 $10.99 4.91
2011-12-31 53.20 $10.75 4.95
2011-09-30 51.19 $11.37 4.50
2011-06-30 52.99 $11.95 4.43
2011-03-31 46.79 $12.45 3.76
2010-12-31 48.41 $12.95 3.74
2010-09-30 48.08 $12.89 3.73
2010-06-30 45.40 $12.27 3.70
2010-03-31 49.67 $11.73 4.23
2009-12-31 48.69 $11.38 4.28
2009-09-30 45.67 $10.70 4.27
2009-06-30 42.26 $10.41 4.06
2009-03-31 38.79 $10.29 3.77
2008-12-31 43.76 $10.40 4.21
2008-09-30 50.27 $10.23 4.91
2008-06-30 46.39 $10.26 4.52
2008-03-31 46.44 $10.54 4.41
2007-12-31 47.44 $10.80 4.39
2007-09-30 46.44 $10.58 4.39
2007-06-30 43.27 $10.17 4.25
2007-03-31 42.04 $9.77 4.30
2006-12-31 45.79 $9.54 4.80
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $346.681B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $237.118B 0.00
Merck (MRK) United States $217.785B 17.91
Novartis AG (NVS) Switzerland $205.270B 17.65
Pfizer (PFE) United States $191.651B 11.29
Novo Nordisk (NVO) Denmark $126.560B 21.00
AstraZeneca (AZN) United Kingdom $112.309B 22.51
Eli Lilly (LLY) United States $106.700B 19.91
Sanofi (SNY) France $104.896B 12.93
GlaxoSmithKline (GSK) United Kingdom $99.695B 12.60
AbbVie (ABBV) United States $95.259B 7.63
Bristol-Myers Squibb (BMY) United States $76.848B 10.90
Bayer (BAYRY) Germany $66.954B 9.76
H Lundbeck (HLUYY) Denmark $8.015B 11.57